A US BUDGET IMPACT MODEL FOR SELINEXOR IN COMBINATION WITH DEXAMETHASONE FOR THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM)

被引：0
|
作者：
Bassali, J. [1 ]
Gould, I [2 ]
Mladsi, D. D. [2 ]
Kaye, J. A. [3 ]
Shah, J. [1 ]
Mehta, J. [4 ]
机构：
[1] Karyopharm Therapeut, Newton, MA USA
[2] RTI Hlth Solut, Res Triangle Pk, NC USA
[3] RTI Hlth Solut, Waltham, MA USA
[4] Karyopharm Therapeut, Lexington, MA USA
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN58
引用
收藏
页码：S33 / S33
页数：1
相关论文
共 50 条
  • [41] Phase I Trial of Ibrutinib, Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)
    Ailawadhi, Sikander
    Paulus, Aneel
    Alegria, Victoria R.
    Laplant, Betsy
    Moustafa, Muhamad Alhaj
    Chapin, Dustin
    Jackson, Keisha
    Jani, Prachi
    Ahmed, Salman
    Edwards, Brett
    Manna, Alak
    Roy, Vivek
    Sher, Taimur
    Chanan-Khan, Asher A.
    BLOOD, 2019, 134
  • [42] Selinexor, Bortezomib, and Dexamethasone (SVD) in Heavily Treated Relapsed Refractory Multiple Myeloma
    Mouhieddine, Tarek
    Parekh, Samir
    Cho, Hearn Jay
    Richter, Joshua
    DeCastro, Andrew
    Shah, Jatin
    Landesman, Yosef
    Chari, Ajai
    Jagannath, Sundar
    Madduri, Deepu
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S292 - S293
  • [43] Once Weekly Oral Selinexor, Pomalidomide, and Dexamethasone in Relapsed Refractory Multiple Myeloma
    White, Darrell J.
    Chen, Christine I.
    Baljevic, Muhamed
    Tuchman, Sascha A.
    Bahlis, Nizar J.
    Schiller, Gary J.
    Lipe, Brea
    Kotb, Rami
    Sutherland, Heather J.
    Bensinger, William I.
    Madan, Sumit
    Sebag, Michael
    Lentzsch, Suzanne
    Callander, Natalie S.
    Biran, Noa
    Venner, Christopher P.
    Leblanc, Richard
    Monge, Jorge
    Chubar, Evgeni
    Tadmor, Tamar
    Lavi, Noa
    Leiba, Merav
    De Castro, Andrew
    Van Domelen, Dane R.
    Zhang, Chris
    Mishal, Moran
    Bentur, Ohad S.
    Shah, Jatin J.
    Shacham, Sharon
    Kauffman, Michael G.
    Gasparetto, Cristina J.
    BLOOD, 2021, 138
  • [44] Treatment patterns among patients with relapsed/refractory multiple myeloma (RRMM) in Taiwan
    Huang, Jeffrey Shang-Yi
    Wang, Ming-Chung
    Yeh, Su-Peng
    Chen, Tsai-Yun
    Teng, Chieh-Lin Jerry
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S188 - S189
  • [45] PRACTICE PATTERNS AND OUTCOMES IN ELDERLY US PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
    Romanus, D.
    Raju, A.
    Yong, C.
    Seal, B.
    Farrelly, E.
    Labotka, R.
    Jhaveri, M.
    Noga, S.
    Blazer, M.
    Parameswaran, H.
    HAEMATOLOGICA, 2016, 101 : 532 - 533
  • [46] Selinexor, bortezomib, and dexamethasone (SVD) in heavily treated relapsed refractory multiple myeloma
    Mouhieddine, Tarek H.
    Parekh, Samir
    Cho, Hearn Jay
    Richter, Joshua
    DeCastro, Andrew
    Shah, Jatin
    Landesman, Yosef
    Chari, Ajai
    Jagannath, Sundar
    Madduri, Deepu
    ANNALS OF HEMATOLOGY, 2021, 100 (12) : 3057 - 3060
  • [47] Selinexor, bortezomib, and dexamethasone (SVD) in heavily treated relapsed refractory multiple myeloma
    Tarek H. Mouhieddine
    Samir Parekh
    Hearn Jay Cho
    Joshua Richter
    Andrew DeCastro
    Jatin Shah
    Yosef Landesman
    Ajai Chari
    Sundar Jagannath
    Deepu Madduri
    Annals of Hematology, 2021, 100 : 3057 - 3060
  • [48] Cost Offsets in the Treatment Journeys of Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
    Ailawadhi, Sikander
    DerSarkissian, Maral
    Duh, Mei Sheng
    Lafeuille, Marie-Helene
    Posner, George
    Ralston, Stephen
    Zagadailov, Erin
    Ba-Mancini, Abbie
    Rifkin, Robert M.
    BLOOD, 2017, 130
  • [49] CLINICAL AND TREATMENT CHARACTERISTICS OF PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) IN EUROPE
    Oriol, A.
    Steinmetz, T.
    Patel, V
    Kutikova, L.
    Schmidt, N.
    Hennies, N.
    Thiess, A.
    Kostev, K.
    Leleu, X.
    VALUE IN HEALTH, 2019, 22 : S497 - S498
  • [50] Pomalidomide alone or in combination with dexamethasone in Japanese patients with refractory or relapsed and refractory multiple myeloma
    Matsue, Kosei
    Iwasaki, Hiromi
    Chou, Takaaki
    Tobinai, Kensei
    Sunami, Kazutaka
    Ogawa, Yoshiaki
    Kurihara, Mari
    Midorikawa, Shuichi
    Zaki, Mohamed
    Doerr, Thomas
    Iida, Shinsuke
    CANCER SCIENCE, 2015, 106 (11): : 1561 - 1567
12345